Our mission

Cervical cancer is the second leading cause of death for women worldwide; 85% of deaths occur in low and middle-income countries (LMICs), despite the fact that well-established interventions exist for pre-invasive disease.

Many low-resource countries lack the health care infrastructure required for the cytology-based screening and referral colposcopic diagnosis that have dramatically reduced the disease burden in wealthier countries. Our vision is to sustainably improve women's access to cancer prevention.

Meet our Team
Contact us >>
Marlee Krieger, MS
Chief Executive Officer
Clinical study and grant management
Regulatory
Mercy Asiedu, Ph.D

chief technology officer
Biomedical engineering,
machine learning,
global health
Jenna Mueller, Ph.D
Project Engineer
Biomedical Engineering,
global health,
optics
Nimmi Ramanujam, Ph.D
Chief Scientific Advisor
Biomedical Engineering,
global health,
optics
Chris Lam, Ph.D
Project Engineer Biomedical Engineering, global health, optics
Our Advisors
Industrial Design
3rd Stone Design
Industrial Design
Blur Product Development
Sales and Distribution
Onco Prev Internacional
Sales and Distribution
Cure Medical
Business Advisors

Karthik Gopalakrishnan PhD
Ken Gall PhD
Krishna Udayakuma MD MBA
Clinical Advisors
John Schmitt MD
Groesbeck Parham MD
Jose Jeronimo MD
Patty Garcia MD
Roopa Hariprasad MD
Ravi Mehrotra MD
Neerja Bhatla MD
Jayashree Natarajan MD

Art exhibit to create awareness for cervical cancer and reproduction of the Callascope

Our time educating & spreading awareness in Ghana

Midwife at La Liga Contra El Cancer Mobile Clinic testing out the Pocket Colposcope

Art exhibit to create awareness for cervical cancer and reproduction of the Callascope

Interviewing Dr. Srofenyoh

Our time educating & spreading awareness in Ghana

Team visits a Mobile cervical cancer screening van in Lima, Peru